TrialAntimicrobial agents and chemotherapy2024

Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171.

Hong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.